- Home
- UNCY vs CVGI Comparison
UNCY vs CVGI Comparison
Compare UNCY & CVGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UNCY
- CVGI
- Stock Information
- Founded
- UNCY 2016
- CVGI 2000
- Country
- UNCY United States
- CVGI United States
- Employees
- UNCY N/A
- CVGI N/A
- Industry
- UNCY Biotechnology: Pharmaceutical Preparations
- CVGI Auto Parts:O.E.M.
- Sector
- UNCY Health Care
- CVGI Consumer Discretionary
- Exchange
- UNCY Nasdaq
- CVGI Nasdaq
- Market Cap
- UNCY 71.8M
- CVGI 71.8M
- IPO Year
- UNCY 2021
- CVGI 2004
- Fundamental
- Price
- UNCY $0.62
- CVGI $1.19
- Analyst Decision
- UNCY Strong Buy
- CVGI Buy
- Analyst Count
- UNCY 3
- CVGI 1
- Target Price
- UNCY $5.50
- CVGI $10.00
- AVG Volume (30 Days)
- UNCY 510.7K
- CVGI 464.1K
- Earning Date
- UNCY 05-16-2025
- CVGI 05-06-2025
- Dividend Yield
- UNCY N/A
- CVGI N/A
- EPS Growth
- UNCY N/A
- CVGI N/A
- EPS
- UNCY N/A
- CVGI N/A
- Revenue
- UNCY N/A
- CVGI $698,524,000.00
- Revenue This Year
- UNCY N/A
- CVGI N/A
- Revenue Next Year
- UNCY $1,502.84
- CVGI $6.33
- P/E Ratio
- UNCY N/A
- CVGI N/A
- Revenue Growth
- UNCY N/A
- CVGI N/A
- 52 Week Low
- UNCY $0.20
- CVGI $0.81
- 52 Week High
- UNCY $1.16
- CVGI $6.31
- Technical
- Relative Strength Index (RSI)
- UNCY 51.83
- CVGI 56.69
- Support Level
- UNCY $0.59
- CVGI $0.88
- Resistance Level
- UNCY $0.66
- CVGI $1.12
- Average True Range (ATR)
- UNCY 0.03
- CVGI 0.12
- MACD
- UNCY -0.00
- CVGI 0.04
- Stochastic Oscillator
- UNCY 40.05
- CVGI 86.07
About UNCY Unicycive Therapeutics Inc.
Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.
About CVGI Commercial Vehicle Group Inc.
Commercial Vehicle Group Inc is a supplier of cab-related products and systems. Its operating segments are Vehicle Solutions, Industrial Automation, Electrical Systems, and Aftermarket and Accessories. Vehicle Solutions segment designs manufacture and sell Commercial vehicle seats and Plastic components. Warehouse Automation segment designs, manufactures, and sells Warehouse automation subsystems including control panels, electro-mechanical assemblies, cable assemblies, and power and communication solutions. Electrical Systems segment designs, manufactures and sells cable and harness assemblies for both high and low voltage applications, control boxes, dashboard assemblies, and design and engineering for these applications. The company makes majority of its revenue from Vehicle Solutions.